This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Supporting Improved Patient Onboarding and Adherence with Training Solutions
Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Product Solutions
Using in vitro dissolution tests for local bioequivalence in OINDPs
Webinars, Pharmaceutical, Innovation & Insights, Market Insights
Demonstrating bioequivalence in generic orally inhaled drug products
Publications, Pharmaceutical, Innovation & Insights
Patient training and onboarding for intranasal rescue treatments
Publications, Pharmaceutical, Product Solutions, Innovation & Insights, Device Innovations
